BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, supplying promising improvements throughout a variety of healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, much more responsible option for therapeutic use, s